Clinical trial Recruiting at 2 sites Interventional Ages 20 and up

New cardiac MRI technique using a specialized coil

Official title: The Next Leap in Cardiac Magnetic Resonance Imaging:Cycling the Field The TITAN Study

Run by University of Aberdeen · NCT04458883 · Data updated 2026-11-12

This study is testing a new MRI technique with a special coil to see if it can provide better images of heart tissue for both healthy people and those who have had heart attacks.

Quick facts

Study typeInterventional
Ages20 Years and up
SexAll
Enrollment150 (estimated)
SponsorUniversity of Aberdeen
Academic / other
Locations2 sites (Aberdeen, Aberdeenshire and 1 other locations)
StatusRecruiting
StartedAugust 1, 2020
Main results expectedJuly 31, 2027
Study endsJuly 31, 2027
Registry record updatedApril 30, 2026
Trial IDNCT04458883 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include healthy volunteers and patients diagnosed with a previous myocardial infarction.

Probably not a fit

Patients with claustrophobia, certain cardiac devices, or other undisclosed heart conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to develop and test a cardiac-specific coil for Fast Field-Cycling MRI, a novel imaging technique that rapidly switches field strengths to provide detailed information about heart tissue. Researchers at the University of Aberdeen will create this coil and establish normal T1 dispersion curves for healthy hearts, while also distinguishing characteristics of scar tissue in patients who have experienced a myocardial infarction. The study will involve both healthy volunteers and patients with a history of heart attacks to assess the effectiveness of this new imaging approach.

Why it matters

Potential benefit: If successful, this technique could lead to improved cardiac imaging and better diagnosis of myocardial infarction and related conditions.

How similar studies have gone: While Fast Field-Cycling MRI is a novel approach, similar imaging techniques have shown promise in other studies, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participant who is willing and able to give informed consent for participation in the study
* Healthy volunteers willing to give informed consent for participation in the study
* Patients diagnosed with a previous myocardial infarction

Exclusion Criteria:

* Unwillingness to participate
* Claustrophobia
* Contraindication to MRI scanning such as implantable cardiac devices
* Participants who have had a previous myocardial infarction in the past of which they may not be aware and this is discovered whilst being scanned on the 3T MRI scanner, or who may have any other cardiology condition that they were previously unaware will not be included in the healthy control group, even if they present themselves to us as "healthy" at the time of the study visit
* Pregnancy
* Body habitus that may preclude comfortable positioning of the volunteer in either of the MRI scanners (\>50cm in diameter)
* Participants with abnormal kidney function that will preclude them from receiving a contrast agent

Where it's running

  • Cardiovascular Research Facility
    Aberdeen, Aberdeenshire, United Kingdom
    Recruiting
  • University of Aberdeen and NHS Grampian
    Aberdeen, Aberdeenshire, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.